138 related articles for article (PubMed ID: 12870051)
1. Analysis of p16 gene mutations and deletions in childhood acute lymphoblastic leukemias.
Lemos JA; Defavery R; Scrideli CA; Tone LG
Sao Paulo Med J; 2003 Mar; 121(2):58-62. PubMed ID: 12870051
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the p15 gene in children with acute lymphoblastic leukemia.
Cipolotti R; Lemos JA; Defavery R; Scrideli CA; Dal Fabbro AL; Tone LG
Sao Paulo Med J; 2003 Sep; 121(5):203-6. PubMed ID: 14666292
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
[TBL] [Abstract][Full Text] [Related]
4. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood.
Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y
Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987
[TBL] [Abstract][Full Text] [Related]
5. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.
Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A
Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234
[TBL] [Abstract][Full Text] [Related]
6. Alterations of p16 and p15 genes in acute leukemia with MLL gene rearrangements and their correlation with clinical features.
Ohnishi H; Guo SX; Ida K; Taki T; Naritaka S; Bessho F; Yanagisawa M; Hanada R; Eguchi M; Kamada N; Kita K; Yamamori S; Hayashi Y
Leukemia; 1997 Dec; 11(12):2120-4. PubMed ID: 9447829
[TBL] [Abstract][Full Text] [Related]
7. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features.
Fizzotti M; Cimino G; Pisegna S; Alimena G; Quartarone C; Mandelli F; Pelicci PG; Lo Coco F
Blood; 1995 May; 85(10):2685-90. PubMed ID: 7742527
[TBL] [Abstract][Full Text] [Related]
8. [Deletions and aberrant transcription of p16 and p15 genes in childhood acute lymphoblastic leukemia].
Fu G; Lu C; Zhang R
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):366-8. PubMed ID: 11721435
[TBL] [Abstract][Full Text] [Related]
9. INK4A/ARF deletions are acquired at relapse in childhood acute lymphoblastic leukaemia: a paired study on 25 patients using real-time polymerase chain reaction.
Carter TL; Reaman GH; Kees UR
Br J Haematol; 2001 May; 113(2):323-8. PubMed ID: 11380395
[TBL] [Abstract][Full Text] [Related]
10. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
Drexler HG
Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
[TBL] [Abstract][Full Text] [Related]
11. p16 gene homozygous deletions in acute lymphoblastic leukemia.
Quesnel B; Preudhomme C; Philippe N; Vanrumbeke M; Dervite I; Lai JL; Bauters F; Wattel E; Fenaux P
Blood; 1995 Feb; 85(3):657-63. PubMed ID: 7833469
[TBL] [Abstract][Full Text] [Related]
12. Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia.
Agarwal M; Bakhshi S; Dwivedi SN; Kabra M; Shukla R; Seth R
Pediatr Blood Cancer; 2018 Jun; 65(6):e27001. PubMed ID: 29446543
[TBL] [Abstract][Full Text] [Related]
13. Alterations of CDKN2 gene structure in childhood acute lymphoblastic leukemia: mutations of CDKN2 are observed preferentially in T lineage.
Nakao M; Yokota S; Kaneko H; Seriu T; Koizumi S; Takaue Y; Fujimoto T; Misawa S
Leukemia; 1996 Feb; 10(2):249-54. PubMed ID: 8637233
[TBL] [Abstract][Full Text] [Related]
14. Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias.
Guidal-Giroux C; Gérard B; Cavé H; Duval M; Rohrlich P; Elion J; Vilmer E; Grandchamp B
Br J Haematol; 1996 Feb; 92(2):410-9. PubMed ID: 8603008
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
17. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
[TBL] [Abstract][Full Text] [Related]
18. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations.
Maloney KW; McGavran L; Odom LF; Hunger SP
Leukemia; 1998 Sep; 12(9):1417-21. PubMed ID: 9737691
[TBL] [Abstract][Full Text] [Related]
19. Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.
Friedrich MG; Blind C; Milde-Langosch K; Erbersdobler A; Conrad S; Löning T; Hammerer P; Huland H
Eur Urol; 2001 Nov; 40(5):518-24. PubMed ID: 11752859
[TBL] [Abstract][Full Text] [Related]
20. P16 gene deletions and point mutations in patients with agnogenic myeloid metaplasia (AMM).
Wang JC; Chen C
Leuk Res; 1999 Jul; 23(7):631-5. PubMed ID: 10400184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
